Integrative network toxicology and clinical validation identify CD4, PTGS2, and KDR as candidate targets of nicotine in infantile hemangioma

Shulin Luo, Ziliang Chen, Dequan Liu, Mingde Liao, Jinglu Hu, Feiyi Du, Chong Liu, Bojie Lin

Open source

DOI
10.1016/j.gene.2026.150485
Published
2026-11
Container
Gene
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.gene.2026.150485,
  title = {Integrative network toxicology and clinical validation identify CD4, PTGS2, and KDR as candidate targets of nicotine in infantile hemangioma},
  author = {Shulin Luo and Ziliang Chen and Dequan Liu and Mingde Liao and Jinglu Hu and Feiyi Du and Chong Liu and Bojie Lin},
  year = {2026},
  journal = {Gene},
  doi = {10.1016/j.gene.2026.150485},
  url = {https://doi.org/10.1016/j.gene.2026.150485}
}

RIS

TY  - JOUR
TI  - Integrative network toxicology and clinical validation identify CD4, PTGS2, and KDR as candidate targets of nicotine in infantile hemangioma
AU  - Shulin Luo
AU  - Ziliang Chen
AU  - Dequan Liu
AU  - Mingde Liao
AU  - Jinglu Hu
AU  - Feiyi Du
AU  - Chong Liu
AU  - Bojie Lin
PY  - 2026
JO  - Gene
DO  - 10.1016/j.gene.2026.150485
UR  - https://doi.org/10.1016/j.gene.2026.150485
ER  - 

APA

Luo, S., Chen, Z., Liu, D., Liao, M., Hu, J., Du, F., Liu, C., & Lin, B. (2026). Integrative network toxicology and clinical validation identify CD4, PTGS2, and KDR as candidate targets of nicotine in infantile hemangioma. Gene. https://doi.org/10.1016/j.gene.2026.150485

Source records